• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·002805.SZ
Share

Shandong Fengyuan Chemical Co., Ltd. Stocks

CN¥ 21.9Last Updated 26.05.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

CN¥ 926.41M

CN¥ 21.9
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable price performance

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Shandong Fengyuan Chemical Co., Ltd. develops, produces, and sells industrial oxalic acid, refined oxalic acid, and oxalate products in China and internationally. It also provides potassium tetroxalate, lithium iron phosphate, potassium binoxalate, sodium nitrate, and lithium cathode materials. The company's products are mainly used in pharmaceutical, rare earth, fine chemical, daily chemicals, textile printing and dyeing, and other industries, as well as biopharmaceutical, new energy vehicles, energy conservation and environmental protection, and various other fields. Shandong Fengyuan Chemical Co., Ltd. was founded in 2000 and is based in Zaozhuang, China.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.05.2026 18:17

Trump risks triggering financial crisis with war with Iran, ECB warned

27.05.2026 17:27

Analyst doesn't advise shares of cannabis seller Tilray: even Trump's executive order won't help him

27.05.2026 16:55

Oil prices fell after Iran's statements on the "low" likelihood of a renewed war

27.05.2026 16:13

Hong Kong has surpassed Switzerland to become the largest offshore hub

27.05.2026 16:01

Morning in New York: quotes require new drivers

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026